0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Contraceptive Drug Eluting Devices Market Research Report 2026
Published Date: 2026-02-03
|
Report Code: QYRE-Auto-21F18464
Home | Market Reports | Health| Reproductive Health
Global Contraceptive Drug Eluting Devices Market Research Report 2024
BUY CHAPTERS

Global Contraceptive Drug Eluting Devices Market Research Report 2026

Code: QYRE-Auto-21F18464
Report
2026-02-03
Pages:135
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Contraceptive Drug Eluting Devices Market Size

The global Contraceptive Drug Eluting Devices market was valued at US$ 4471 million in 2025 and is anticipated to reach US$ 5822 million by 2032, at a CAGR of 3.9% from 2026 to 2032.

Contraceptive Drug Eluting Devices Market

Contraceptive Drug Eluting Devices Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Contraceptive Drug Eluting Devices competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Contraceptive Drug-Eluting Devices are medical devices designed to release contraceptive drugs over a prolonged period to prevent pregnancy. These devices are implanted in the body or placed in specific areas, gradually releasing hormones that inhibit ovulation or prevent sperm from fertilizing an egg. Common examples include intrauterine devices (IUDs) and subdermal implants, which are effective, reversible, and provide long-term contraception without requiring daily action.
The North American market for Contraceptive Drug Eluting Devices is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Contraceptive Drug Eluting Devices is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Contraceptive Drug Eluting Devices include Bayer, AbbVie, CooperSurgical, Egemen International, ERENLER MEDIKAL, Gyneas, Laboratoire CCD, Medical Engineering Corporation, Melbea, Meril Life Sciences, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Contraceptive Drug Eluting Devices market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Contraceptive Drug Eluting Devices. The Contraceptive Drug Eluting Devices market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Contraceptive Drug Eluting Devices market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Contraceptive Drug Eluting Devices manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Contraceptive Drug Eluting Devices Market Report

Report Metric Details
Report Name Contraceptive Drug Eluting Devices Market
Accounted market size in 2025 US$ 4471 million
Forecasted market size in 2032 US$ 5822 million
CAGR 3.9%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Non-biodegradable
  • Biodegradable
by Application
  • Subcutaneously
  • Uterus
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bayer, AbbVie, CooperSurgical, Egemen International, ERENLER MEDIKAL, Gyneas, Laboratoire CCD, Medical Engineering Corporation, Melbea, Meril Life Sciences, Mona Lisa, Pregna International, Prosan International, Rongbo Medical, SMB Corporation of India, Pregna
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Contraceptive Drug Eluting Devices manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Contraceptive Drug Eluting Devices sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Contraceptive Drug Eluting Devices Market growing?

Ans: The Contraceptive Drug Eluting Devices Market witnessing a CAGR of 3.9% during the forecast period 2026-2032.

What is the Contraceptive Drug Eluting Devices Market size in 2032?

Ans: The Contraceptive Drug Eluting Devices Market size in 2032 will be US$ 5822 million.

Who are the main players in the Contraceptive Drug Eluting Devices Market report?

Ans: The main players in the Contraceptive Drug Eluting Devices Market are Bayer, AbbVie, CooperSurgical, Egemen International, ERENLER MEDIKAL, Gyneas, Laboratoire CCD, Medical Engineering Corporation, Melbea, Meril Life Sciences, Mona Lisa, Pregna International, Prosan International, Rongbo Medical, SMB Corporation of India, Pregna

What are the Application segmentation covered in the Contraceptive Drug Eluting Devices Market report?

Ans: The Applications covered in the Contraceptive Drug Eluting Devices Market report are Subcutaneously, Uterus

What are the Type segmentation covered in the Contraceptive Drug Eluting Devices Market report?

Ans: The Types covered in the Contraceptive Drug Eluting Devices Market report are Non-biodegradable, Biodegradable

1 Contraceptive Drug Eluting Devices Market Overview
1.1 Product Definition
1.2 Contraceptive Drug Eluting Devices by Type
1.2.1 Global Contraceptive Drug Eluting Devices Market Value by Type: 2025 vs 2032
1.2.2 Non-biodegradable
1.2.3 Biodegradable
1.3 Contraceptive Drug Eluting Devices by Application
1.3.1 Global Contraceptive Drug Eluting Devices Market Value by Application: 2025 vs 2032
1.3.2 Subcutaneously
1.3.3 Uterus
1.4 Global Contraceptive Drug Eluting Devices Market Size Estimates and Forecasts
1.4.1 Global Contraceptive Drug Eluting Devices Revenue 2021–2032
1.4.2 Global Contraceptive Drug Eluting Devices Sales 2021–2032
1.4.3 Global Contraceptive Drug Eluting Devices Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Contraceptive Drug Eluting Devices Market Competition by Manufacturers
2.1 Global Contraceptive Drug Eluting Devices Sales Market Share by Manufacturers (2021–2026)
2.2 Global Contraceptive Drug Eluting Devices Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Contraceptive Drug Eluting Devices Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Contraceptive Drug Eluting Devices, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Contraceptive Drug Eluting Devices, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Contraceptive Drug Eluting Devices, Product Types and Applications
2.7 Global Key Manufacturers of Contraceptive Drug Eluting Devices, Date of Entry into the Industry
2.8 Global Contraceptive Drug Eluting Devices Market Competitive Situation and Trends
2.8.1 Global Contraceptive Drug Eluting Devices Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Contraceptive Drug Eluting Devices Players Market Share by Revenue
2.8.3 Global Contraceptive Drug Eluting Devices Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Contraceptive Drug Eluting Devices Market Scenario by Region
3.1 Global Contraceptive Drug Eluting Devices Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Contraceptive Drug Eluting Devices Sales by Region: 2021–2032
3.2.1 Global Contraceptive Drug Eluting Devices Sales by Region: 2021–2026
3.2.2 Global Contraceptive Drug Eluting Devices Sales by Region: 2027–2032
3.3 Global Contraceptive Drug Eluting Devices Revenue by Region: 2021–2032
3.3.1 Global Contraceptive Drug Eluting Devices Revenue by Region: 2021–2026
3.3.2 Global Contraceptive Drug Eluting Devices Revenue by Region: 2027–2032
3.4 North America Contraceptive Drug Eluting Devices Market Facts & Figures by Country
3.4.1 North America Contraceptive Drug Eluting Devices Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Contraceptive Drug Eluting Devices Sales by Country (2021–2032)
3.4.3 North America Contraceptive Drug Eluting Devices Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Contraceptive Drug Eluting Devices Market Facts & Figures by Country
3.5.1 Europe Contraceptive Drug Eluting Devices Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Contraceptive Drug Eluting Devices Sales by Country (2021–2032)
3.5.3 Europe Contraceptive Drug Eluting Devices Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Contraceptive Drug Eluting Devices Market Facts & Figures by Region
3.6.1 Asia Pacific Contraceptive Drug Eluting Devices Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Contraceptive Drug Eluting Devices Sales by Region (2021–2032)
3.6.3 Asia Pacific Contraceptive Drug Eluting Devices Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Contraceptive Drug Eluting Devices Market Facts & Figures by Country
3.7.1 Latin America Contraceptive Drug Eluting Devices Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Contraceptive Drug Eluting Devices Sales by Country (2021–2032)
3.7.3 Latin America Contraceptive Drug Eluting Devices Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Contraceptive Drug Eluting Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Contraceptive Drug Eluting Devices Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Contraceptive Drug Eluting Devices Sales by Country (2021–2032)
3.8.3 Middle East and Africa Contraceptive Drug Eluting Devices Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Contraceptive Drug Eluting Devices Sales by Type (2021–2032)
4.1.1 Global Contraceptive Drug Eluting Devices Sales by Type (2021–2026)
4.1.2 Global Contraceptive Drug Eluting Devices Sales by Type (2027–2032)
4.1.3 Global Contraceptive Drug Eluting Devices Sales Market Share by Type (2021–2032)
4.2 Global Contraceptive Drug Eluting Devices Revenue by Type (2021–2032)
4.2.1 Global Contraceptive Drug Eluting Devices Revenue by Type (2021–2026)
4.2.2 Global Contraceptive Drug Eluting Devices Revenue by Type (2027–2032)
4.2.3 Global Contraceptive Drug Eluting Devices Revenue Market Share by Type (2021–2032)
4.3 Global Contraceptive Drug Eluting Devices Price by Type (2021–2032)
5 Segment by Application
5.1 Global Contraceptive Drug Eluting Devices Sales by Application (2021–2032)
5.1.1 Global Contraceptive Drug Eluting Devices Sales by Application (2021–2026)
5.1.2 Global Contraceptive Drug Eluting Devices Sales by Application (2027–2032)
5.1.3 Global Contraceptive Drug Eluting Devices Sales Market Share by Application (2021–2032)
5.2 Global Contraceptive Drug Eluting Devices Revenue by Application (2021–2032)
5.2.1 Global Contraceptive Drug Eluting Devices Revenue by Application (2021–2026)
5.2.2 Global Contraceptive Drug Eluting Devices Revenue by Application (2027–2032)
5.2.3 Global Contraceptive Drug Eluting Devices Revenue Market Share by Application (2021–2032)
5.3 Global Contraceptive Drug Eluting Devices Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Company Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Contraceptive Drug Eluting Devices Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Bayer Contraceptive Drug Eluting Devices Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 AbbVie
6.2.1 AbbVie Company Information
6.2.2 AbbVie Description and Business Overview
6.2.3 AbbVie Contraceptive Drug Eluting Devices Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 AbbVie Contraceptive Drug Eluting Devices Product Portfolio
6.2.5 AbbVie Recent Developments/Updates
6.3 CooperSurgical
6.3.1 CooperSurgical Company Information
6.3.2 CooperSurgical Description and Business Overview
6.3.3 CooperSurgical Contraceptive Drug Eluting Devices Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 CooperSurgical Contraceptive Drug Eluting Devices Product Portfolio
6.3.5 CooperSurgical Recent Developments/Updates
6.4 Egemen International
6.4.1 Egemen International Company Information
6.4.2 Egemen International Description and Business Overview
6.4.3 Egemen International Contraceptive Drug Eluting Devices Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Egemen International Contraceptive Drug Eluting Devices Product Portfolio
6.4.5 Egemen International Recent Developments/Updates
6.5 ERENLER MEDIKAL
6.5.1 ERENLER MEDIKAL Company Information
6.5.2 ERENLER MEDIKAL Description and Business Overview
6.5.3 ERENLER MEDIKAL Contraceptive Drug Eluting Devices Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 ERENLER MEDIKAL Contraceptive Drug Eluting Devices Product Portfolio
6.5.5 ERENLER MEDIKAL Recent Developments/Updates
6.6 Gyneas
6.6.1 Gyneas Company Information
6.6.2 Gyneas Description and Business Overview
6.6.3 Gyneas Contraceptive Drug Eluting Devices Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Gyneas Contraceptive Drug Eluting Devices Product Portfolio
6.6.5 Gyneas Recent Developments/Updates
6.7 Laboratoire CCD
6.7.1 Laboratoire CCD Company Information
6.7.2 Laboratoire CCD Description and Business Overview
6.7.3 Laboratoire CCD Contraceptive Drug Eluting Devices Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Laboratoire CCD Contraceptive Drug Eluting Devices Product Portfolio
6.7.5 Laboratoire CCD Recent Developments/Updates
6.8 Medical Engineering Corporation
6.8.1 Medical Engineering Corporation Company Information
6.8.2 Medical Engineering Corporation Description and Business Overview
6.8.3 Medical Engineering Corporation Contraceptive Drug Eluting Devices Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Medical Engineering Corporation Contraceptive Drug Eluting Devices Product Portfolio
6.8.5 Medical Engineering Corporation Recent Developments/Updates
6.9 Melbea
6.9.1 Melbea Company Information
6.9.2 Melbea Description and Business Overview
6.9.3 Melbea Contraceptive Drug Eluting Devices Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Melbea Contraceptive Drug Eluting Devices Product Portfolio
6.9.5 Melbea Recent Developments/Updates
6.10 Meril Life Sciences
6.10.1 Meril Life Sciences Company Information
6.10.2 Meril Life Sciences Description and Business Overview
6.10.3 Meril Life Sciences Contraceptive Drug Eluting Devices Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Meril Life Sciences Contraceptive Drug Eluting Devices Product Portfolio
6.10.5 Meril Life Sciences Recent Developments/Updates
6.11 Mona Lisa
6.11.1 Mona Lisa Company Information
6.11.2 Mona Lisa Description and Business Overview
6.11.3 Mona Lisa Contraceptive Drug Eluting Devices Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Mona Lisa Contraceptive Drug Eluting Devices Product Portfolio
6.11.5 Mona Lisa Recent Developments/Updates
6.12 Pregna International
6.12.1 Pregna International Company Information
6.12.2 Pregna International Description and Business Overview
6.12.3 Pregna International Contraceptive Drug Eluting Devices Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Pregna International Contraceptive Drug Eluting Devices Product Portfolio
6.12.5 Pregna International Recent Developments/Updates
6.13 Prosan International
6.13.1 Prosan International Company Information
6.13.2 Prosan International Description and Business Overview
6.13.3 Prosan International Contraceptive Drug Eluting Devices Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Prosan International Contraceptive Drug Eluting Devices Product Portfolio
6.13.5 Prosan International Recent Developments/Updates
6.14 Rongbo Medical
6.14.1 Rongbo Medical Company Information
6.14.2 Rongbo Medical Description and Business Overview
6.14.3 Rongbo Medical Contraceptive Drug Eluting Devices Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Rongbo Medical Contraceptive Drug Eluting Devices Product Portfolio
6.14.5 Rongbo Medical Recent Developments/Updates
6.15 SMB Corporation of India
6.15.1 SMB Corporation of India Company Information
6.15.2 SMB Corporation of India Description and Business Overview
6.15.3 SMB Corporation of India Contraceptive Drug Eluting Devices Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 SMB Corporation of India Contraceptive Drug Eluting Devices Product Portfolio
6.15.5 SMB Corporation of India Recent Developments/Updates
6.16 Pregna
6.16.1 Pregna Company Information
6.16.2 Pregna Description and Business Overview
6.16.3 Pregna Contraceptive Drug Eluting Devices Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Pregna Contraceptive Drug Eluting Devices Product Portfolio
6.16.5 Pregna Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Contraceptive Drug Eluting Devices Industry Chain Analysis
7.2 Contraceptive Drug Eluting Devices Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Contraceptive Drug Eluting Devices Production Mode & Process Analysis
7.4 Contraceptive Drug Eluting Devices Sales and Marketing
7.4.1 Contraceptive Drug Eluting Devices Sales Channels
7.4.2 Contraceptive Drug Eluting Devices Distributors
7.5 Contraceptive Drug Eluting Devices Customer Analysis
8 Contraceptive Drug Eluting Devices Market Dynamics
8.1 Contraceptive Drug Eluting Devices Industry Trends
8.2 Contraceptive Drug Eluting Devices Market Drivers
8.3 Contraceptive Drug Eluting Devices Market Challenges
8.4 Contraceptive Drug Eluting Devices Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Contraceptive Drug Eluting Devices Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Contraceptive Drug Eluting Devices Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Contraceptive Drug Eluting Devices Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Contraceptive Drug Eluting Devices Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Contraceptive Drug Eluting Devices Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Contraceptive Drug Eluting Devices Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Contraceptive Drug Eluting Devices Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Contraceptive Drug Eluting Devices Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Contraceptive Drug Eluting Devices, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Contraceptive Drug Eluting Devices, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Contraceptive Drug Eluting Devices, Product Types and Applications
 Table 12. Global Key Manufacturers of Contraceptive Drug Eluting Devices, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Contraceptive Drug Eluting Devices Companies by Tier (Tier 1, Tier 2, Tier 3), based on Contraceptive Drug Eluting Devices Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Contraceptive Drug Eluting Devices Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Contraceptive Drug Eluting Devices Sales by Region (K Units), 2021–2026
 Table 18. Global Contraceptive Drug Eluting Devices Sales Market Share by Region (2021–2026)
 Table 19. Global Contraceptive Drug Eluting Devices Sales by Region (K Units), 2027–2032
 Table 20. Global Contraceptive Drug Eluting Devices Sales Market Share by Region (2027–2032)
 Table 21. Global Contraceptive Drug Eluting Devices Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Contraceptive Drug Eluting Devices Revenue Market Share by Region (2021–2026)
 Table 23. Global Contraceptive Drug Eluting Devices Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Contraceptive Drug Eluting Devices Revenue Market Share by Region (2027–2032)
 Table 25. North America Contraceptive Drug Eluting Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Contraceptive Drug Eluting Devices Sales by Country (K Units), 2021–2026
 Table 27. North America Contraceptive Drug Eluting Devices Sales by Country (K Units), 2027–2032
 Table 28. North America Contraceptive Drug Eluting Devices Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Contraceptive Drug Eluting Devices Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Contraceptive Drug Eluting Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Contraceptive Drug Eluting Devices Sales by Country (K Units), 2021–2026
 Table 32. Europe Contraceptive Drug Eluting Devices Sales by Country (K Units), 2027–2032
 Table 33. Europe Contraceptive Drug Eluting Devices Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Contraceptive Drug Eluting Devices Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Contraceptive Drug Eluting Devices Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Contraceptive Drug Eluting Devices Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Contraceptive Drug Eluting Devices Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Contraceptive Drug Eluting Devices Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Contraceptive Drug Eluting Devices Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Contraceptive Drug Eluting Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Contraceptive Drug Eluting Devices Sales by Country (K Units), 2021–2026
 Table 42. Latin America Contraceptive Drug Eluting Devices Sales by Country (K Units), 2027–2032
 Table 43. Latin America Contraceptive Drug Eluting Devices Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Contraceptive Drug Eluting Devices Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Contraceptive Drug Eluting Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Contraceptive Drug Eluting Devices Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Contraceptive Drug Eluting Devices Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Contraceptive Drug Eluting Devices Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Contraceptive Drug Eluting Devices Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Contraceptive Drug Eluting Devices Sales (K Units) by Type (2021–2026)
 Table 51. Global Contraceptive Drug Eluting Devices Sales (K Units) by Type (2027–2032)
 Table 52. Global Contraceptive Drug Eluting Devices Sales Market Share by Type (2021–2026)
 Table 53. Global Contraceptive Drug Eluting Devices Sales Market Share by Type (2027–2032)
 Table 54. Global Contraceptive Drug Eluting Devices Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Contraceptive Drug Eluting Devices Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Contraceptive Drug Eluting Devices Revenue Market Share by Type (2021–2026)
 Table 57. Global Contraceptive Drug Eluting Devices Revenue Market Share by Type (2027–2032)
 Table 58. Global Contraceptive Drug Eluting Devices Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Contraceptive Drug Eluting Devices Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Contraceptive Drug Eluting Devices Sales (K Units) by Application (2021–2026)
 Table 61. Global Contraceptive Drug Eluting Devices Sales (K Units) by Application (2027–2032)
 Table 62. Global Contraceptive Drug Eluting Devices Sales Market Share by Application (2021–2026)
 Table 63. Global Contraceptive Drug Eluting Devices Sales Market Share by Application (2027–2032)
 Table 64. Global Contraceptive Drug Eluting Devices Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Contraceptive Drug Eluting Devices Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Contraceptive Drug Eluting Devices Revenue Market Share by Application (2021–2026)
 Table 67. Global Contraceptive Drug Eluting Devices Revenue Market Share by Application (2027–2032)
 Table 68. Global Contraceptive Drug Eluting Devices Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Contraceptive Drug Eluting Devices Price (US$/Unit) by Application (2027–2032)
 Table 70. Bayer Company Information
 Table 71. Bayer Description and Business Overview
 Table 72. Bayer Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Bayer Contraceptive Drug Eluting Devices Product
 Table 74. Bayer Recent Developments/Updates
 Table 75. AbbVie Company Information
 Table 76. AbbVie Description and Business Overview
 Table 77. AbbVie Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. AbbVie Contraceptive Drug Eluting Devices Product
 Table 79. AbbVie Recent Developments/Updates
 Table 80. CooperSurgical Company Information
 Table 81. CooperSurgical Description and Business Overview
 Table 82. CooperSurgical Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. CooperSurgical Contraceptive Drug Eluting Devices Product
 Table 84. CooperSurgical Recent Developments/Updates
 Table 85. Egemen International Company Information
 Table 86. Egemen International Description and Business Overview
 Table 87. Egemen International Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Egemen International Contraceptive Drug Eluting Devices Product
 Table 89. Egemen International Recent Developments/Updates
 Table 90. ERENLER MEDIKAL Company Information
 Table 91. ERENLER MEDIKAL Description and Business Overview
 Table 92. ERENLER MEDIKAL Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. ERENLER MEDIKAL Contraceptive Drug Eluting Devices Product
 Table 94. ERENLER MEDIKAL Recent Developments/Updates
 Table 95. Gyneas Company Information
 Table 96. Gyneas Description and Business Overview
 Table 97. Gyneas Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Gyneas Contraceptive Drug Eluting Devices Product
 Table 99. Gyneas Recent Developments/Updates
 Table 100. Laboratoire CCD Company Information
 Table 101. Laboratoire CCD Description and Business Overview
 Table 102. Laboratoire CCD Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Laboratoire CCD Contraceptive Drug Eluting Devices Product
 Table 104. Laboratoire CCD Recent Developments/Updates
 Table 105. Medical Engineering Corporation Company Information
 Table 106. Medical Engineering Corporation Description and Business Overview
 Table 107. Medical Engineering Corporation Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Medical Engineering Corporation Contraceptive Drug Eluting Devices Product
 Table 109. Medical Engineering Corporation Recent Developments/Updates
 Table 110. Melbea Company Information
 Table 111. Melbea Description and Business Overview
 Table 112. Melbea Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Melbea Contraceptive Drug Eluting Devices Product
 Table 114. Melbea Recent Developments/Updates
 Table 115. Meril Life Sciences Company Information
 Table 116. Meril Life Sciences Description and Business Overview
 Table 117. Meril Life Sciences Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Meril Life Sciences Contraceptive Drug Eluting Devices Product
 Table 119. Meril Life Sciences Recent Developments/Updates
 Table 120. Mona Lisa Company Information
 Table 121. Mona Lisa Description and Business Overview
 Table 122. Mona Lisa Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Mona Lisa Contraceptive Drug Eluting Devices Product
 Table 124. Mona Lisa Recent Developments/Updates
 Table 125. Pregna International Company Information
 Table 126. Pregna International Description and Business Overview
 Table 127. Pregna International Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Pregna International Contraceptive Drug Eluting Devices Product
 Table 129. Pregna International Recent Developments/Updates
 Table 130. Prosan International Company Information
 Table 131. Prosan International Description and Business Overview
 Table 132. Prosan International Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. Prosan International Contraceptive Drug Eluting Devices Product
 Table 134. Prosan International Recent Developments/Updates
 Table 135. Rongbo Medical Company Information
 Table 136. Rongbo Medical Description and Business Overview
 Table 137. Rongbo Medical Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 138. Rongbo Medical Contraceptive Drug Eluting Devices Product
 Table 139. Rongbo Medical Recent Developments/Updates
 Table 140. SMB Corporation of India Company Information
 Table 141. SMB Corporation of India Description and Business Overview
 Table 142. SMB Corporation of India Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 143. SMB Corporation of India Contraceptive Drug Eluting Devices Product
 Table 144. SMB Corporation of India Recent Developments/Updates
 Table 145. Pregna Company Information
 Table 146. Pregna Description and Business Overview
 Table 147. Pregna Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 148. Pregna Contraceptive Drug Eluting Devices Product
 Table 149. Pregna Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Contraceptive Drug Eluting Devices Distributors List
 Table 153. Contraceptive Drug Eluting Devices Customers List
 Table 154. Contraceptive Drug Eluting Devices Market Trends
 Table 155. Contraceptive Drug Eluting Devices Market Drivers
 Table 156. Contraceptive Drug Eluting Devices Market Challenges
 Table 157. Contraceptive Drug Eluting Devices Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Contraceptive Drug Eluting Devices
 Figure 2. Global Contraceptive Drug Eluting Devices Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Contraceptive Drug Eluting Devices Market Share by Type: 2025 & 2032
 Figure 4. Non-biodegradable Product Picture
 Figure 5. Biodegradable Product Picture
 Figure 6. Global Contraceptive Drug Eluting Devices Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Contraceptive Drug Eluting Devices Market Share by Application: 2025 & 2032
 Figure 8. Subcutaneously
 Figure 9. Uterus
 Figure 10. Global Contraceptive Drug Eluting Devices Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 11. Global Contraceptive Drug Eluting Devices Market Size (US$ Million), 2021–2032
 Figure 12. Global Contraceptive Drug Eluting Devices Sales (K Units), 2021–2032
 Figure 13. Global Contraceptive Drug Eluting Devices Average Price (US$/Unit), 2021–2032
 Figure 14. Contraceptive Drug Eluting Devices Report Years Considered
 Figure 15. Contraceptive Drug Eluting Devices Sales Share by Manufacturers in 2025
 Figure 16. Global Contraceptive Drug Eluting Devices Revenue Share by Manufacturers in 2025
 Figure 17. Top 5 and Top 10 Global Contraceptive Drug Eluting Devices Players: Market Share by Revenue in Contraceptive Drug Eluting Devices in 2025
 Figure 18. Contraceptive Drug Eluting Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 19. Global Contraceptive Drug Eluting Devices Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 20. North America Contraceptive Drug Eluting Devices Sales Market Share by Country (2021–2032)
 Figure 21. North America Contraceptive Drug Eluting Devices Revenue Market Share by Country (2021–2032)
 Figure 22. United States Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 23. Canada Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Europe Contraceptive Drug Eluting Devices Sales Market Share by Country (2021–2032)
 Figure 25. Europe Contraceptive Drug Eluting Devices Revenue Market Share by Country (2021–2032)
 Figure 26. Germany Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. France Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. U.K. Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Italy Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Russia Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Asia Pacific Contraceptive Drug Eluting Devices Sales Market Share by Region (2021–2032)
 Figure 32. Asia Pacific Contraceptive Drug Eluting Devices Revenue Market Share by Region (2021–2032)
 Figure 33. China Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Japan Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. South Korea Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. India Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Australia Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. China Taiwan Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Southeast Asia Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Latin America Contraceptive Drug Eluting Devices Sales Market Share by Country (2021–2032)
 Figure 41. Latin America Contraceptive Drug Eluting Devices Revenue Market Share by Country (2021–2032)
 Figure 42. Mexico Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Brazil Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Argentina Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Colombia Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Middle East and Africa Contraceptive Drug Eluting Devices Sales Market Share by Country (2021–2032)
 Figure 47. Middle East and Africa Contraceptive Drug Eluting Devices Revenue Market Share by Country (2021–2032)
 Figure 48. Turkey Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Saudi Arabia Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. UAE Contraceptive Drug Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Global Sales Market Share of Contraceptive Drug Eluting Devices by Type (2021–2032)
 Figure 52. Global Revenue Market Share of Contraceptive Drug Eluting Devices by Type (2021–2032)
 Figure 53. Global Contraceptive Drug Eluting Devices Price (US$/Unit) by Type (2021–2032)
 Figure 54. Global Sales Market Share of Contraceptive Drug Eluting Devices by Application (2021–2032)
 Figure 55. Global Revenue Market Share of Contraceptive Drug Eluting Devices by Application (2021–2032)
 Figure 56. Global Contraceptive Drug Eluting Devices Price (US$/Unit) by Application (2021–2032)
 Figure 57. Contraceptive Drug Eluting Devices Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS